Harvest Fund Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Harvest Fund Management's BMY Position: Q2 2026 in Review
Harvest Fund Management reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, selling an estimated $76K and leaving 8,547 shares worth $492K. The position accounts for 0.02% of the portfolio, ranked #205.
Harvest Fund Management first reported a position in BMY in Q3 2018 and has held it in 22 quarters since. The position peaked at $820K in Q4 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Harvest Fund Management held 8,547 shares of Bristol-Myers Squibb worth $492K as of Q2 2026.
- Harvest Fund Management sold 1,323 Bristol-Myers Squibb shares in Q2 2026, an estimated $76K.
- Bristol-Myers Squibb made up 0.02% of Harvest Fund Management's portfolio in Q2 2026, its #205 holding.
- Harvest Fund Management first reported a position in Bristol-Myers Squibb in Q3 2018 and has held it in 22 quarters since.
- Harvest Fund Management's Bristol-Myers Squibb position peaked at $820K in Q4 2019.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Harvest Fund Management's 13F filing for Q2 2026, filed 20 Aug 2026.